Back to Treatments

Treatment

Pembrolizumab (Keytruda)

1
Conditions
117
Trials
5,000
Participants
50%
Average Safety

Condition Evidence

Bladder cancer

117 trials · 5,000 participants

65% effectiveness · 50% safety
Pembrolizumab (Keytruda) | DFDA